[go: up one dir, main page]

CU22737A1 - Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico - Google Patents

Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico

Info

Publication number
CU22737A1
CU22737A1 CU1997047A CU1997047A CU22737A1 CU 22737 A1 CU22737 A1 CU 22737A1 CU 1997047 A CU1997047 A CU 1997047A CU 1997047 A CU1997047 A CU 1997047A CU 22737 A1 CU22737 A1 CU 22737A1
Authority
CU
Cuba
Prior art keywords
fusion proteins
recombinant fusion
development
bacterial
diagnostic tests
Prior art date
Application number
CU1997047A
Other languages
English (en)
Inventor
Avila Marta Ayala
Garcia Hansell Bell
Almeida Freya De Los Milagros Freyre
Cowley Jorge Victor Gavilondo
Porto Marta Gloria Duenas
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Priority to CU1997047A priority Critical patent/CU22737A1/es
Priority to EP98916797A priority patent/EP0978564A1/en
Priority to CA002288348A priority patent/CA2288348A1/en
Priority to PCT/CU1998/000005 priority patent/WO1998049327A1/es
Priority to AU70277/98A priority patent/AU741043B2/en
Publication of CU22737A1 publication Critical patent/CU22737A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención está relacionada con el campo de la biotecnología, en particular con el desarrollo de proteinas de fusión recombinantes basadas en adhesinas bacterianas y su uso en ensayos diagnósticos de hemaglutinación para la detección específica de anticuerpos o antígenos en sangre y otras muestras biológicas. Su objetivo técnico es obtener proteínas de fusión recombinantes, o conjugados bioquímicos, útiles para el desarrollo de sistemas simples de ensayo diagnóstico, basados en adhesinas bacterianas o sus dominios de interacción molecular con las células rojas. El uso de proteínas de adhesión de E. coli como base de proteínas recombinantes de fusión con actividad de unión a eritrocitos humanos, favorece las características de expresión en este hospedero, eliminando problemas potenciales en los rendimientos de producción asociados a la toxicidad bacteriana.
CU1997047A 1997-04-28 1997-04-28 Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico CU22737A1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CU1997047A CU22737A1 (es) 1997-04-28 1997-04-28 Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico
EP98916797A EP0978564A1 (en) 1997-04-28 1998-04-27 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays
CA002288348A CA2288348A1 (en) 1997-04-28 1998-04-27 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays
PCT/CU1998/000005 WO1998049327A1 (es) 1997-04-28 1998-04-27 Proteinas de fusion recombinantes basadas en adhesinas bacterianas para el desarollo de ensayos diagnosticos
AU70277/98A AU741043B2 (en) 1997-04-28 1998-04-27 Recombinant fusion proteins based on bacterial adhesins for diagnostic assays

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997047A CU22737A1 (es) 1997-04-28 1997-04-28 Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico

Publications (1)

Publication Number Publication Date
CU22737A1 true CU22737A1 (es) 2002-02-28

Family

ID=5459262

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1997047A CU22737A1 (es) 1997-04-28 1997-04-28 Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico

Country Status (5)

Country Link
EP (1) EP0978564A1 (es)
AU (1) AU741043B2 (es)
CA (1) CA2288348A1 (es)
CU (1) CU22737A1 (es)
WO (1) WO1998049327A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6017422B2 (ja) 2010-08-10 2016-11-02 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） 赤血球結合療法
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EA201691686A1 (ru) 2014-02-21 2017-03-31 Эколь Политекник Федераль Де Лозан (Эпфл) Терапевтические средства с углевод-опосредованной адресной доставкой
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US11253579B2 (en) 2017-06-16 2022-02-22 The University Of Chicago Compositions and methods for inducing immune tolerance
IL278538B2 (en) 2018-05-09 2024-01-01 Univ Chicago Compositions and methods concerning immune tolerance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA08953A (fr) * 1987-09-17 1990-11-30 Agen Ltd Agglutination assay
JPH07506727A (ja) * 1992-05-22 1995-07-27 アジェン・リミテッド 凝集アッセイ用試薬

Also Published As

Publication number Publication date
WO1998049327A1 (es) 1998-11-05
WO1998049327A8 (es) 2000-03-16
AU741043B2 (en) 2001-11-22
AU7027798A (en) 1998-11-24
CA2288348A1 (en) 1998-11-05
EP0978564A1 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
ATE324912T1 (de) Zell- und serumproteinanker und konjugate
DE69840448D1 (de) 13c,15n,2h markierte proteine zur nmr strukturbestimmung und deren herstellung
DE10075010I1 (de) Fusionsproteine mit immunglobulinanteilen ihre Herstellung und Verwendung
KR910005862A (ko) 신규 친수성 유도체, 진단 또는 치료시 그의 응용 그를 함유하는 진단 또는 치료용 키트 및 면역 시약
CU22737A1 (es) Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico
BRPI0413495A (pt) reagentes de peptìdeos especìficos para prìons e seus usos
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DK1111385T3 (da) Enzym-protein-kompleks
SE8505458D0 (sv) Bakteriofager som igenkennings- och identifieringsmedel
Friis et al. Influence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitro
DE69728897D1 (de) Saeugetierchemokine
DE69131133D1 (de) Verwendung von gro-genen und proteinen
DE69028094D1 (de) Konjugate von antikörpern mit variablen domänen
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
DE60037676D1 (de) Verfahren zur diagnose von rickettsia pulicis
Tabuchi et al. Self-contained on-chip cell culture and pretreatment system
DE69316388D1 (de) CRF Bindungsproteine
EP1837655A4 (en) BLOCKED ENZYME CONDENSATE COMPLEX
DE60040485D1 (de) Molekulardisplay auf multimeren proteingerüsten, die von der e2 komponente der alpha-ketosäure-dehydrogenase stammen
Toole The Development of Optical Biosensors for the detection of proteins in solution
FR2841988B1 (fr) Methode de diagnostic serologique comprenant un controle positif de l'introduction d'un serum humain a tester
Lindon et al. Platelet activation by polyalkyl acrylates and methacrylates: the role of surface-bound fibrinogen
Rüdiger et al. Cell based strain stiffening of a non-fibrous matrix as organizing principle for morphogenesis
Goding Membrane protein protocols
SE9803993D0 (sv) New reagent and use thereof